Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 golcadomide study in relapsed or refractory CNS large B-cell lymphoma
NL-OMON60570Phase 2Recruiting
- Sponsor
- HOVON
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of golcadomide, sponsored by HOVON. Started Sep 2025; status: recruiting.
02
Drugs
golcadomide
Beyond the preview
Go deeper on NL-OMON60570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60570.